Suwon-si, South Korea

Young-An Bae

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Contributions of Young-An Bae to Antimalarial Research

Introduction: Young-An Bae, located in Suwon-si, South Korea, is a notable inventor recognized for his significant contributions to the field of parasitic disease treatment. With a focus on developing innovative methods for inhibiting malaria, his work underscores the importance of scientific advancements in healthcare.

Latest Patents: Young-An Bae holds a patent for the use of vivapain-4 (VX-4), a cysteine protease of Plasmodium vivax. This patent details a method of treating diseases caused by this parasite by inhibiting VX-4. Additionally, it includes techniques for screening protease inhibitors that can act on VX-4, suggesting their potential as anti-malarial agents. The patent also provides a method for identifying the activity of VX-4, which is crucial for the development of effective treatments against malaria.

Career Highlights: Young-An Bae is associated with Samsung Electronics Co., Ltd., where he applies his expertise in biotechnology and protease research. His impactful work not only aids in the understanding of malaria but also supports the broader goal of developing new therapeutic options for parasitic diseases.

Collaborations: In his professional journey, Young-An collaborates with esteemed colleagues such as Yoon Kong and Byoung-Kuk Na. These collaborations enhance the research efforts and innovative solutions being pursued within his team, contributing to advancements in the field.

Conclusion: Young-An Bae exemplifies the spirit of innovation in the pursuit of medical breakthroughs. His patent on VX-4 not only addresses the urgent need for effective malaria treatments but also showcases the importance of collaboration in scientific research. As he continues his work at Samsung Electronics, the potential for further advancements in parasitic disease treatment remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…